No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Molecular imaging and the unification of multilevel mechanisms and data in medical physics
2.A. D. Chesler, Symposium on Tomographic Imaging in Nuclear Medicine, New York, 1972.
3.D. E. Kuhl, R. Q. Edwards, A. R. Ricci, and M. Reivich, “Quantitative section scanning using orthogonal tangent correction,” J. Nucl. Med. 14, 196–200 (1973).
4.H. W. Strauss, B. L. Zaret, N. D. Martin, H. P. Wells, Jr., and M. D. Flamm, Jr., “Noninvasive evaluation of regional myocardial perfusion with potassium 43. Technique in patients with exercise-induced transient myocardial ischemia,” Radiology 108, 85–90 (1973).
5.H. N. Wagner, A Personal History of Nuclear Medicine (Springer, London, 2006).
6.T. Beyer, D. W. Townsend, T. Brun, P. E. Kinahan, M. Charron, R. Roddy, J. Jerin, J. Young, L. Byars, and R. Nutt, “A combined PET/CT scanner for clinical oncology,” J. Nucl. Med. 41, 1369–1379 (2000).
7.S. C. Blankespoor, X. Xu, K. Kaiki, J. K. Brown, H. R. Tang, C. E. Cann, and B. H. Hasegawa, “Attenuation correction of SPECT using x-ray CT on an emission-transmission CT system: Myocardial perfusion assessment,” IEEE Trans. Nucl. Sci. 43, 2263–2274 (1996).
10.A. Alavi, A. Mavi, S. Basu, and A. Fischman, “Is PET-CT the only option?,” Eur. J. Nucl. Med. Mol. Imaging 34, 819–821 (2007).
11.H. Zaidi, “The quest for the ideal anato-molecular imaging fusion tool,” Biomed. Imaging Interv. J. 2, e47 (2006).
12.B. Wessels, “The value of PET/CT is being over-sold as a clinical tool in radiation oncology. Against the proposition,” Med. Phys. 32, 1458–1459 (2005).
13.L. Xing, “The value of PET/CT is being over-sold as a clinical tool in radiation oncology. For the proposition,” Med. Phys. 32, 1457–1458 (2005).
14.E. H. Shortliffe and J. J. Cimino, in Health Informatics, edited by K. J. Hannah and M. J. Ball (Springer, New York, 2006).
15.G. C. Kagadis, P. Nagy, S. Langer, M. Flynn, and G. Starkschall, “Anniversary paper: Roles of medical physicists and health care applications of informatics,” Med. Phys. 35, 119–127 (2008).
17.W. Sujansky, “Heterogeneous database integration in biomedicine,” J. Biomed. Inform. 34, 285–298 (2001).
18.D. S. Wang, M. D. Dake, J. M. Park, and M. D. Kuo, “Molecular imaging: A primer for interventionalists and imagers,” J. Vasc. Interv. Radiol. 17, 1405–1423 (2006).
19.B. Louie, P. Mork, F. Martin-Sanchez, A. Halevy, and P. Tarczy-Hornoch, “Data integration and genomic medicine,” J. Biomed. Inform. 40, 5–16 (2007).
20.R. J. Gillies, “In vivo molecular imaging,” J. Cell. Biochem. Suppl. 39, 231–238 (2002).
21.R. Weissleder and U. Mahmood, “Molecular imaging,” Radiology 219, 316–333 (2001).
22.G. D. Luker, “Special conference of the American Association for Cancer Research on molecular imaging in cancer: Linking biology, function, and clinical applications in vivo,” Cancer Res. 62, 2195–2198 (2002).
23.R. Blasberg, “PET imaging of gene expression,” Eur. J. Cancer 38, 2137–2146 (2002).
24.V. Sharma, G. D. Luker, and D. Piwnica-Worms, “Molecular imaging of gene expression and protein function in vivo with PET and SPECT,” J. Magn. Reson. Imaging 16, 336–351 (2002).
25.E. P. Krenning et al., “Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients,” Eur. J. Nucl. Med. 20, 716–731 (1993).
26.J. Lister-James, S. Vallabhajosula, B. R. Moyer, D. A. Pearson, B. J. McBride, M. A. De Rosch, L. R. Bush, J. Machac, and R. T. Dean, “Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide,” J. Nucl. Med. 38, 105–111 (1997).
27.D. L. Prout, R. W. Silverman, and A. Chatziioannou, “Detector concept for OPET-A combined PET and optical imaging system,” IEEE Trans. Nucl. Sci. 51, 752–756 (2004).
28.C. -Y. Chou, Y. Huang, D. Shi, and M. A. Anastasio, “Image reconstruction in quantitative x-ray phase-contrast imaging employing multiple measurements,” Opt. Express 15, 10002 (2007).
29.J. E. Bender, A. J. Kapadia, A. C. Sharma, G. D. Tourassi, B. P. Harrawood, and C. E. Floyd, Jr., “Breast cancer detection using neutron stimulated emission computed tomography: Prominent elements and dose requirements,” Med. Phys. 34, 3866–3871 (2007).
31.Y. W. Cho, S. A. Park, T. H. Han, D. H. Son, J. S. Park, S. J. Oh, D. H. Moon, K. J. Cho, C. H. Ahn, Y. Byun, I. S. Kim, I. C. Kwon, and S. Y. Kim, “In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: Mechanisms, key factors, and their implications,” Biomaterials 28, 1236–1247 (2007).
32.T. Cyrus, D. R. Abendschein, S. D. Caruthers, T. D. Harris, V. Glattauer, J. A. Werkmeister, J. A. Ramshaw, S. A. Wickline, and G. M. Lanza, “MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles,” J. Cardiovasc. Magn. Reson. 8, 535–541 (2006).
33.K. C. Partlow, J. Chen, J. A. Brant, A. M. Neubauer, T. E. Meyerrose, M. H. Creer, J. A. Nolta, S. D. Caruthers, G. M. Lanza, and S. A. Wickline, “19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons,” FASEB J. 21, 1647–1654 (2007).
34.J. D. Woodward, S. J. Kennel, S. Mirzadeh, S. Dai, J. S. Wall, T. Richey, J. Avenell, and A. J. Rondinone, “In vivo SPECT/CT imaging and biodistribution using radioactive Cd125mTe/ZnS nanoparticles,” Nanotechnology 18, 175103–175108 (2007).
35.E. D. Pressly, R. Rossin, A. Hagooly, K. Fukukawa, B. W. Messmore, M. J. Welch, K. L. Wooley, M. S. Lamm, R. A. Hule, D. J. Pochan, and C. J. Hawker, “Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined (64)Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers,” Biomacromolecules 8, 3126–3134 (2007).
36.Z. Burbar, R. Grazioso, and J. Corbeil, “PET performance of MR/PET brain insert tomograph [abstr],” IEEE Nuclear Science Symposium and Medical Imaging Conference, San Diego, California, 2006.
37.M. S. Judenhofer, C. Catana, B. K. Swann, S. B. Siegel, W. I. Jung, R. E. Nutt, S. R. Cherry, C. D. Claussen, and B. J. Pichler, “PET/MR images acquired with a compact MR-compatible PET detector in a 7-T magnet,” Radiology 244, 807–814 (2007).
38.H. Zaidi, O. Mawlawi, and C. G. Orton, “Point/counterpoint. Simultaneous PET/MR will replace PET/CT as the molecular multimodality imaging platform of choice,” Med. Phys. 34, 1525–1528 (2007).
39.S. J. Norton and T. Vo-Dinh, “Imaging the distribution of magnetic nanoparticles with ultrasound,” IEEE Trans. Med. Imaging 26, 660–665 (2007).
40.A. Uedono, K. Ito, T. Narumi, M. Sometani, K. Yamabe, Y. Miyagawa, T. Murata, K. Honda, N. Hattori, M. Matsuura, K. Asai, T. Ohdaira, and R. Suzuki, “Annealing properties of open volumes in strained SiN films studied by monoenergetic positron beams,” J. Appl. Phys. 102, 064513 (2007).
41.R. K. Schmidt-Ullrich, “Molecular targets in radiation oncology,” Oncogene 22, 5730–5733 (2003).
42.C. N. Coleman, “Linking radiation oncology and imaging through molecular biology (or now that therapy and diagnosis have separated, it’s time to get together again!),” Radiology 228, 29–35 (2003).
43.G. D. Fullerton, “The development of technologies for molecular imaging should be driven principally by biological questions to be addressed rather than by simply modifying existing imaging technologies. For the proposition,” Med. Phys. 32, 1231–1232 (2005).
44.J. D. Hazle, “The development of technologies for molecular imaging should be driven principally by biological questions to be addressed rather than by simply modifying existing imaging technologies. Against the proposition,” Med. Phys. 32, 1232–1233 (2005).
45.U. M. Dohn, B. J. Ejbjerg, M. Hasselquist, E. Narvestad, J. Moller, H. S. Thomsen, and M. Ostergaard, “Detection of bone erosions in rheumatoid arthritis wrist joints with magnetic resonance imaging, computed tomography and radiography,” Arthritis Res. Ther. 10, R25 (2008).
46.M. Knupp, A. Skoog, H. Tornkvist, and S. Ponzer, “Triple arthrodesis in rheumatoid arthritis,” Foot Ankle Int. 29, 293–297 (2008).
49.J. P. Carney, D. W. Townsend, V. Rappoport, and B. Bendriem, “Method for transforming CT images for attenuation correction in PET/CT imaging,” Med. Phys. 33, 976–983 (2006).
50.S. Ozgocmen, H. Ozdemir, A. Kiris, Z. Bozgeyik, and O. Ardicoglu, “Clinical evaluation and power Doppler sonography in rheumatoid arthritis: Evidence for ongoing synovial inflammation in clinical remission,” South. Med. J. 101, 240–245 (2008).
51.E. H. Elzinga, C. J. van der Laken, E. F. Comans, A. A. Lammertsma, B. A. Dijkmans, and A. E. Voskuyl, “2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: Rheumatoid arthritis versus osteoarthritis,” Mol. Imaging Biol. 9, 357–360 (2007).
52.F. M. McQueen and M. Ostergaard, “Established rheumatoid arthritis—New imaging modalities,” Best Pract. Res. Clin. Rheumatol. 21, 841–856 (2007).
53.G. Alexandrakis, F. R. Rannou, and A. F. Chatziioannou, “Tomographic bioluminescence imaging by use of a combined optical-PET (OPET) system: A computer simulation feasibility study,” Phys. Med. Biol. 50, 4225–4241 (2005).
54.T. C. van der Pouw Kraan, L. G. van Baarsen, F. Rustenburg, B. Baltus, M. Fero, and C. L. Verweij, “Gene expression profiling in rheumatology,” Methods Mol. Med. 136, 305–327 (2007).
55.S. Zrioual, M. L. Toh, A. Tournadre, Y. Zhou, M. A. Cazalis, A. Pachot, V. Miossec, and P. Miossec, “IL-17RA and IL-17RC receptors are essential for IL-17A-induced CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood,” J. Immunol. 180, 655–663 (2008).
56.K. Andreas, C. Lubke, T. Haupl, T. Dehne, L. Morawietz, J. Ringe, C. Kaps, and M. Sittinger, “Key regulatory molecules of cartilage destruction in rheumatoid arthritis: An in vitro study,” Arthritis Res. Ther. 10, R9 (2008).
57.A. Daskalakis, D. Cavouras, P. Bougioukos, S. Kostopoulos, D. Glotsos, I. Kalatzis, G. C. Kagadis, C. Argyropoulos, and G. Nikiforidis, “Improving gene quantification by adjustable spot-image restoration,” Bioinformatics 23, 2265–2272 (2007).
58.Y. Juarranz, I. Gutierrez-Canas, B. Santiago, M. Carrion, J. L. Pablos, and R. P. Gomariz, “Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts,” Arthritis Rheum. 58, 1086–1095 (2008).
59.E. Simelyte, G. Criado, D. Essex, R. A. Uger, M. Feldmann, and R. O. Williams, “CD200-FC, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis,” Arthritis Rheum. 58, 1038–1043 (2008).
60.A. Komatsuda, H. Wakui, T. Nimura, and K. I. Sawada, “Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis,” Mod. Rheumatol. 18, 315–318 (2008).
61.J. K. Jackson, T. Higo, W. L. Hunter, and H. M. Burt, “Topoisomerase inhibitors as anti-arthritic agents,” Inflamm. Res. 57, 126–134 (2008).
62.H. Okamoto, Y. Katagiri, A. Kiire, S. Momohara, and N. Kamatani, “Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products,” J. Rheumatol. 35, 752–756 (2008).
63.U. J. Netz, J. Beuthan, and A. H. Hielscher, “Multipixel system for gigahertz frequency-domain optical imaging of finger joints,” Rev. Sci. Instrum. 79, 034301 (2008).
64.X. Wang, D. L. Chamberland, P. L. Carson, J. B. Fowlkes, R. O. Bude, D. A. Jamadar, and B. J. Roessler, “Imaging of joints with laser-based photoacoustic tomography: an animal study,” Med. Phys. 33, 2691–2697 (2006).
65.R. G. Cowell, A. P. Dawid, and S. L. Lauritzen, Probabilistic Networks and Expert Systems (Springer, Berlin, 1999).
66.F. V. Jensen and T. D. Nielsen, Bayesian Networks and Decision Graphs, 2nd ed. (Springer, New York, 2007).
67.R. E. Neapolitan, Learning Bayesian Networks (Pearson Prentice-Hall, Englewood Cliffs, NJ, 2004).
68.J. Pearl, Probabilistic Reasoning in Intelligent Systems (Morgan Kaufmann, San Francisco, CA, 1988).
69.D. Poole, “Logic, knowledge representation, and Bayesian decision theory,” in Computational Logic—CL 2000 (Springer, Berlin/Heidelberg, 2000), Vol. 1861/2000, pp. 70–86.
70.N. Cruz-Ramirez, H. G. Acosta-Mesa, H. Carrillo-Calvet, L. A. Nava-Fernandez, and R. E. Barrientos-Martinez, “Diagnosis of breast cancer using Bayesian networks: A case study,” Comput. Biol. Med. 37, 1553–1564 (2007).
71.J. P. Sacha, L. S. Goodenday, and K. J. Cios, “Bayesian learning for cardiac SPECT image interpretation,” Artif. Intell. Med. 26, 109–143 (2002).
72.G. C. Sakellaropoulos and G. C. Nikiforidis, “Development of a Bayesian network for the prognosis of head injuries using graphical model selection techniques,” Methods Inf. Med. 38, 37–42 (1999).
74.R. Jansen, H. Yu, D. Greenbaum, Y. Kluger, N. J. Krogan, S. Chung, A. Emili, M. Snyder, J. F. Greenblatt, and M. Gerstein, “A Bayesian networks approach for predicting protein-protein interactions from genomic data,” Science 302, 449–453 (2003).
75.S. M. McMahon, “Quantifying the community: Using Bayesian learning networks to find structure and conduct inference in invasions biology,” Biol. Invasions 7, 833–844 (2005).
76.C. J. Needham, J. R. Bradford, A. J. Bulpitt, and D. R. Westhead, “A primer on learning in Bayesian networks for computational biology,” PLOS Comput. Biol. 3, e129 (2007).
77.S. Y. Kim, in Computational Methods in Systems Biology (Springer, Berlin, 2003), Vol. 2602, pp. 104–113.
78.T. S. Kuhn, The Structure of Scientific Revolutions (The University of Chicago Press, Chicago, 1962).
Article metrics loading...
Full text loading...
Most read this month